Strides Pharma Science informs about press release

22 May 2024 Evaluate
Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

910.45 -27.95 (-2.98%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×